NCT07481110 Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
| NCT ID | NCT07481110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Société Algérienne de Formation et Recherche en Oncologie |
| Condition | Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2026-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-08-05 with a primary completion date of 2026-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Eligibility Criteria
Inclusion Criteria: * Patients aged 19 years and older * Histologically confirmed diagnosis of gastric cancer * Patients followed in the participating oncology departments * Informed consent obtained Non Inclusion Criteria: * Histological types other than carcinoma (e.g., GIST, lymphoma, sarcoma, etc.). * Secondary gastric tumors * Participation in an interventional study
Frequently Asked Questions
Who can join the NCT07481110 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07481110 currently recruiting?
Yes, NCT07481110 is actively recruiting participants. Visit ClinicalTrials.gov or contact Société Algérienne de Formation et Recherche en Oncologie to inquire about joining.
Where is the NCT07481110 trial being conducted?
This trial is being conducted at Algiers, Algeria, Algiers, Algeria, Algiers, Algeria, Algiers, Algeria and 11 additional locations.
Who is sponsoring the NCT07481110 clinical trial?
NCT07481110 is sponsored by Société Algérienne de Formation et Recherche en Oncologie. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.